BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Catalent Enhances Cryogenic Capabilities in Japan Facility for Cell and Gene Therapy Development

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational ...

May 25, 2023 | News

West Announces the Inauguration of Its Newly Advanced Facility in Singapore

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today inaugurates its ne...

May 24, 2023 | News

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

The awarded facility includes two manufacturing areas utilizing 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch,...

May 23, 2023 | News

Isabelle Lafosse-Marin Discusses Thermo Fisher Scientific's French Expansion, Ushering in a New Era of Drug Manufacturing Excellence.

Isabelle Lafosse-Marin, Senior Director and General Manager of Thermo Fisher Scientific's Bourgoin site, shed light on the company's expansion in Fra...

May 19, 2023 | News

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Along with these additions to the site leadership team, the company has also appointed Erik Riley as Senior Vice President, Corporate Planning. T...

May 19, 2023 | News

Biomerics Announces Merger with Precision Concepts Medical

The transaction includes the acquisition of the medical business of Precision Concepts International ("PCI") as well as Precision Concepts Group ("PCG"), h...

May 19, 2023 | News

WuXi Biologics Partners with InflaRx to Advance Gohibic for Critically Ill COVID-19 Patients

WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emerge...

May 17, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

Vetter Expands Production Capacities and Services Offered at Its Austrian Site

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the pr...

May 09, 2023 | News

Veranova Appoints Mike Riley as Chief Executive Officer

Over the past two years, Niek Stapel has led the business through its sale from Johnson Matthey (LSE:JMAT) to Altaris, LLC (collectively with its affiliate...

May 04, 2023 | News

Exothera Forms Partnership with Quantoom Biosciences to Launch RNA Business Unit

Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for R...

April 27, 2023 | News

Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia

Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...

April 26, 2023 | News

OBiO Technology Launches New Super Factory in Shanghai with 29 GMP-Grade Production Lines for Gene and Cell Therapy

At the opening ceremony, OBiO showed the holistic process development capability and large-scale GMP manufacturing capacity in variety gene and cell therap...

April 25, 2023 | News

Beyond Automation: Improving Efficiency, Sustainability and Reliability Using Clean-in-Place and Steam-in-Place In-Depth Analytics

Drug manufacturers use clean-in-place (CIP) and steam-in-place (SIP) systems to internally clean equipment between batches to ensure produc...

April 21, 2023 | Opinion | By Jennifer Williams, Product Marketing Manager, Discrete Automation at Emerson www.emerson.com

Stay Connected